Clinical trial
Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active…
NCT00130390 · Romark Laboratories L.C., Industry · Terminated
Key facts
| NCT number | NCT00130390 |
|---|---|
| Title | Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease |
| Official title | Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug, Other |
| Interventions | Nitazoxanide, Placebo |
| Enrollment | 98 |
| Start date | Aug 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Aug 15, 2005 |
| Last update posted | May 31, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: